1
|
Imai T, Naruse M, Machida Y, Fujii G, Mutoh M, Ochiai M, Takahashi M, Nakagama H. Feeding a High-Fat Diet for a Limited Duration Increases Cancer Incidence in a Breast Cancer Model. Nutr Cancer 2023; 75:713-725. [PMID: 36263881 DOI: 10.1080/01635581.2022.2132267] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
High-fat intake by young Asian women impacts the risk of breast cancer. Understanding the underlying molecular mechanisms may be essential for disease prevention in Asia as well as globally. We aimed to examine the effects of corn oil- and animal fat-based high-fat diets (32.9 and 31.4%, respectively, of fat energy ratio as compared to 12.3% in the standard diet) on mammary carcinogenesis and alterations in gene expression and epigenetic statuses in the mammary gland during the growth stages in a rat model. An increased incidence of carcinomas was observed after the cessation of high-fat feeding. In addition, rapid tumor growth and elevations in Celsr2 expression, which may be a result of DNA hypomethylation patterns in the 3' untranslated region of the gene were noted in the animal fat group. In the human breast carcinoma cell line MCF7, a marginal decrease in cell viability was observed following the knockdown of Celsr2, suggesting that the animal fat-associated risk of cancer is partly due to the deregulation of mammary cell proliferation via non-metabolic gene functions. The present results will contribute to the development of strategies for controlling the food-associated risk of breast cancer, particularly in younger age groups.
Collapse
Affiliation(s)
- Toshio Imai
- Central Animal Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.,Department of Animal Experimentation, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | - Mie Naruse
- Department of Animal Experimentation, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | - Yukino Machida
- Central Animal Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | - Gen Fujii
- Division of Carcinogenesis and Prevention, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | - Michihiro Mutoh
- Division of Carcinogenesis and Prevention, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | - Masako Ochiai
- Department of Animal Experimentation, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | - Mami Takahashi
- Central Animal Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan
| | | |
Collapse
|
2
|
Naruse M, Ishigamori R, Imai T. The Unique Genetic and Histological Characteristics of DMBA-Induced Mammary Tumors in an Organoid-Based Carcinogenesis Model. Front Genet 2021; 12:765131. [PMID: 34912374 PMCID: PMC8666664 DOI: 10.3389/fgene.2021.765131] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Accepted: 10/29/2021] [Indexed: 01/23/2023] Open
Abstract
Here, we report a model system using in vitro 7,12-dimethylbenz[a]anthracene (DMBA; 0.6 μM)-treated mammary tissue-derived organoids generated from heterozygous BALB/c-Trp53 knockout mice to induce tumors after injection into the nude mouse subcutis. In parallel, a single oral dose of DMBA (50 mg/kg bodyweight) to the same murine strain induced mammary adenocarcinomas, characterized by biphasic structures differentiated into luminal and myoepithelial lineages and frequent Hras mutations at codon 61. In the present study, the genetic and histological characteristics of DMBA-induced tumors in the organoid-based model were evaluated to validate its similarities to the in vivo study. The organoid-derived tumors were low-grade adenocarcinomas composed of luminal and basal/myoepithelial cells. When the organoid-derived carcinomas were passaged to other nude mice, they partly progressed to squamous cell carcinomas (SCCs). Whole exome sequencing revealed no mutations at Hras codon 61 in the organoid-derived tumors. However, various mutations were detected in other genes such as Tusc3 and Tgfbr2, which have been reported as cancer-associated or homeostatic squamous cell genes. The most common mutational pattern observed in these genes were the G:C to T:A transversions and G:C to A:T transitions, which are not typical of the mutations caused by DMBA treatment. In conclusion, DMBA exhibited carcinogenicity in the both the ex vivo and in vivo mammary carcinogenesis models, albeit with distinct histological and genetical alterations. Further studies are needed to clarify whether organoid-based carcinogenesis models generated following chemical treatment in vitro could be applied to the clarification of the novel mode of action of chemical carcinogenesis.
Collapse
Affiliation(s)
- Mie Naruse
- Central Animal Division, National Cancer Center Research Institute, Tokyo, Japan
| | - Rikako Ishigamori
- Central Animal Division, National Cancer Center Research Institute, Tokyo, Japan
| | - Toshio Imai
- Central Animal Division, National Cancer Center Research Institute, Tokyo, Japan
| |
Collapse
|
3
|
Machida Y, Imai T. Different properties of mammary carcinogenesis induced by two chemical carcinogens, DMBA and PhIP, in heterozygous BALB/c Trp53 knockout mice. Oncol Lett 2021; 22:738. [PMID: 34466150 PMCID: PMC8387855 DOI: 10.3892/ol.2021.12999] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Accepted: 07/02/2021] [Indexed: 12/31/2022] Open
Abstract
Chemical carcinogens, such as 7,12-dimethylbenz[a]anthracene (DMBA) and 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), are known to induce mammary carcinomas in mice and rats. In the present study, the phenotypic and genotypic characteristics of carcinogen-induced mammary carcinogenesis in heterozygous BALB/c tumor protein p53 (Trp53) knockout mice were examined with reference to published data surrounding human breast cancer. A significantly accelerated induction of mammary carcinomas was observed following a single dose of DMBA (50 mg/kg of body weight at 7 weeks of age), and a modest acceleration was induced by PhIP (50 mg/kg of body weight) administered by gavage 6 times/2 weeks from 7 weeks of age. DMBA-induced mammary carcinomas were histopathologically characterized by distinct biphasic structures with luminal and myoepithelial cells, as well as a frequent estrogen receptor expression, and PhIP-induced carcinomas with solid/microacinar structures consisted of pleomorphic cells. Of note, DMBA-induced mammary carcinomas were characterized by a HRas proto-oncogene (Hras) mutation at codon 61, and gene/protein expression indicating MAPK stimulation. PhIP-induced lesions were suspected to be caused by different molecular mechanisms, including Wnt/β-catenin signaling and/or gene mutation-independent PI3K/AKT signaling activation. In conclusion, the present mouse mammary carcinogenesis models, induced by a combination of genetic and exogenous factors, may be utilized (such as the DMBA-induced model with Trp53 gene function deficiency as a model of adenomyoepithelioma, characterized by distinct biphasic cell constituents and Hras mutations), but PhIP-induced models are required to further analyze the genetic/epigenetic mechanisms promoting mammary carcinomas.
Collapse
Affiliation(s)
- Yukino Machida
- Central Animal Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan.,Department of Veterinary Pathology, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan
| | - Toshio Imai
- Central Animal Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan
| |
Collapse
|
4
|
Azzarà A, Chiaramonte A, Filomeni E, Pinto B, Mazzoni S, Piaggi S, Angela Guzzardi M, Bruschi F, Iozzo P, Scarpato R. Increased level of DNA damage in some organs of obese Zucker rats by γ-H2AX analysis. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 2017; 58:477-484. [PMID: 28714549 DOI: 10.1002/em.22115] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/27/2016] [Revised: 06/15/2017] [Accepted: 06/15/2017] [Indexed: 06/07/2023]
Abstract
In a recent study, we showed that lymphocytes of obese Italian children/adolescents displayed levels of double strand breaks (DSB), assayed as serine 139-phosphorylated histone H2AX (γ-H2AX), about eightfold higher than normal weight controls, and that 30% of this damage-generated micronuclei. These findings suggested that obese children could be at increased risk of obesity-mediated cancer later in life. We therefore aimed to assess the level of γ-H2AX in a genetic animal model of obesity (Zucker rat) to identify a genotoxic/carcinogenic risk in some organs. The DSB marker was studied in 3- to 4-week-old rats and in 9- to 13-week-old rats. Paraffin-embedded sections of heart, thyroid, liver, pancreas, lung, kidney, esophagus, and gut from the fa-/fa- (obese) and the fa+/fa- (lean) control animals were processed for immunohistochemistry detection of γ-H2AX. Pancreas (0.0624 ± 0.0195), lung (0.1197 ± 0.0217), esophagus (0.1230 ± 0.0351), kidney (0.1546 ± 0.0149), and gut (0.1724 ± 0.0352) of 9- to 13-week-old obese rats showed a higher proportion of γ-H2AX-positive nuclei, than their lean counterparts (0.0092 ± 0.0033, 0.0416 ± 0.0185, 0.0368 ± 0.0088, 0.0686 ± 0.0318, and 0.0703 ± 0.0239, respectively). No difference was seen in the 3- to 4-week-old age group with regard to obesity, indicating that the DNA damage increased with older age of the rats. We hypothesize that the organs of the obese animals showing high levels of DSB could represent target tissues for the development of obesity-related cancers. Environ. Mol. Mutagen. 58:477-484, 2017. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Alessia Azzarà
- Unità di Genetica, Dipartimento di Biologia, University of Pisa, Via Derna 1, Pisa, 56126, Italy
| | - Anna Chiaramonte
- Unità di Genetica, Dipartimento di Biologia, University of Pisa, Via Derna 1, Pisa, 56126, Italy
| | - Erika Filomeni
- Unità di Genetica, Dipartimento di Biologia, University of Pisa, Via Derna 1, Pisa, 56126, Italy
| | - Barbara Pinto
- Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Via Savi 10, Pisa, 56126, Italy
| | - Stefano Mazzoni
- Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Via Savi 10, Pisa, 56126, Italy
| | - Simona Piaggi
- Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Via Savi 10, Pisa, 56126, Italy
| | | | - Fabrizio Bruschi
- Dipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Via Savi 10, Pisa, 56126, Italy
| | - Patricia Iozzo
- CNR Institute of Clinical Physiology, Via Giuseppe Moruzzi, 1, Pisa, 56124, Italy
| | - Roberto Scarpato
- Unità di Genetica, Dipartimento di Biologia, University of Pisa, Via Derna 1, Pisa, 56126, Italy
| |
Collapse
|